Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bauerle
John G. Bauerle, Wilmington, DE US
| Patent application number | Description | Published |
|---|---|---|
| 20080207861 | Curable base-resistant fluoroelastomers - Compositions of fluoroelastomers containing copolymerized units of tetrafluoroethylene, propylene, a first cure site selected from the group consisting of i) trifluoroethylene, ii) 3,3,3-trifluoropropene-1, iii) 1,2,3,3,3-pentafluoropropylene, iv) 1,1,3,3,3-pentafluoropropylene, and v) 2,3,3,3-tetrafluoropropene, and a second cure site selected from the group consisting of i) copolymerized units of a brominated cure site monomer, ii) copolymerized units of an iodinated cure site monomer, iii) copolymerized units of a chlorinated cure site monomer, iv) brominated endgroups, v) iodinated endgroups and vi) a combination of any of i)-v) are readily curable with polyhydroxy curing systems. The resulting cured articles have a combination of excellent resistance to alkaline fluids, superior tensile properties and compression set resistance, and excellent adhesion to metal substrates. Optionally, the fluoroelastomers may be dual cured by both a polyhydroxy system and an organic peroxide system. | 08-28-2008 |
Klaus Bauerle, Tengen DE
| Patent application number | Description | Published |
|---|---|---|
| 20080261463 | Contact element - The invention relates to a contact element for printed circuit boards, comprising a terminal body that has an insertion opening for the insertion of a conductor and a screw for the fastening by clamping of the conductor within the terminal body. A seating element with a seating surface is detachably fastenable by a fastening element to the contact element. The seating surface has a surface area that is greater than the cross-sectional surface area of the terminal body. | 10-23-2008 |
Patrick Bauerle, Gauting DE
| Patent application number | Description | Published |
|---|---|---|
| 20080317746 | Anti-Il2 Antibodies - The invention relates to a humanized monoclonal antibody or fragment thereof which specifically binds to human interleukin-2 (IL2), wherein said humanized monoclonal antibody neutralizes the activity of human IL2 by binding to said human IL2 prior to, during, and/or subsequent to the binding of said human IL2 to the human IL2-receptor, and wherein the light chain variable region of said humanized monoclonal antibody comprises in its second framework region the contiguous amino acid sequence KAPKA at amino acid positions 42-46. | 12-25-2008 |
| 20090022738 | Multispecific deimmunized CD3-binders - The present invention provides a cytotoxically active CD3 specific binding construct comprising a first domain specifically binding to human CD3 and an Ig-derived second binding domain. Furthermore, a nucleic acid sequence encoding a CD3 specific binding construct of the invention is provided. Further aspects of the invention are vectors and host cells comprising said nucleic acid sequence, a process for the production of the construct of the invention and composition comprising said construct. The invention also provides the use of said constructs for the preparation of pharmacutical compositions for the treatment of particular diseases, a method for the treatment of particular diseases and a kit comprising the binding construct of the invention. | 01-22-2009 |
| 20110256137 | PHARMACEUTICAL COMPOSITION COMPRISING A BISPECIFIC ANTIBODY FOR EPCAM - The present invention provides a pharmaceutical composition comprising a bispecific single chain antibody construct. Said bispecific single chain antibody construct is characterized to comprise or consist of at least two domains, whereby one of said at least two domains specifically binds to human EpCAM and comprises at least one CDR-H3 region comprising the amino acid sequence NXID antigen and a second domain binds to human CD3 antigen. The invention further provides a process for the production of the pharmaceutical composition of the invention, a method for the prevention, treatment or amelioration of a tumorous disease and the use of the disclosed bispecific single chain antibody construct and corresponding means in the prevention, treatment or amelioration of a tumorous disease. | 10-20-2011 |
Peter Bauerle, Elchingen-1 DE
| Patent application number | Description | Published |
|---|---|---|
| 20090235971 | PHOTOACTIVE DEVICE WITH ORGANIC LAYERS - The invention relates to a photoactive device with organic layers, especially a solar cell, with a layer arrangement having an electrode and a counterelectrode as well as a sequence of organic layers arranged between the electrode and the counterelectrode, wherein two layers bordering on one another are formed in a photoactive region encompassed by the sequence of organic layers, namely, an exciton-harvesting layer (EHL) and an exciton-separating layer (ESL); in which the exciton-harvesting layer (EHL) is a mixed layer containing an organic material (A) and at least one further organic material (B), in which (i) a lowest singlet excitation state for excitons (S | 09-24-2009 |
Ronald Bauerle, Erie, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20080202376 | Altitude Compensation System for Naturally Aspirated Railroad Locomotive - A railroad locomotive includes a naturally aspirated reciprocating internal combustion engine driving a traction generator. A speed control system and load regulator provide an output signal which is operated upon and modified by a controller in response to the barometric pressure at which the locomotive is being operated. | 08-28-2008 |
Ronald David Bauerle, Erie, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090278674 | METHODS AND SYSTEMS FOR AUTOMATED EMERGENCY LIGHTING - A control circuit for activating at least one emergency light when a vehicle's brakes are applied is described. The control circuit includes a pressure switch configured to selectively couple a power source and an electronically-operated actuator to facilitate selectively energizing the electronically-operated actuator. The electronically-operated actuator includes at least one contact set configured to couple the power source to the at least one emergency light when the electronically-operated actuator is not energized. The control circuit also includes a manual reset circuit coupled to the pressure switch and to the electronically-operated actuator. The manual reset circuit configured to facilitate energizing the electronically-operated actuator upon receipt of an operator input. | 11-12-2009 |
Stefan A. Bauerle, Rauenberg DE
| Patent application number | Description | Published |
|---|---|---|
| 20120023130 | FACILITATION OF EXTENSION FIELD USAGE BASED ON REFERENCE FIELD USAGE - A system may include presentation, to a user, of a consuming business entity including a reference field of a business object, reception of an instruction from the user to add an extension field to the consuming business entity based on the reference field of the business object, determination of a second consuming business entity including the reference field of the business object, and presentation of the second consuming business entity to the user. | 01-26-2012 |